Related Experiment Video
Updated: Feb 14, 2026

07:04
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
Published on: October 24, 2017
9.0K
[Meningioma and pregnancy].
János Bencze1, Gréta Varkoly1, Tibor Hortobágyi1,2
1Debreceni Egyetem, Általános Orvostudományi Kar, Patológiai Intézet, Neuropatológiai Tanszék, Debrecen.
Summary
Meningiomas, common brain tumors, can grow rapidly during pregnancy due to hormonal and hemodynamic factors. Understanding these mechanisms is key to improving treatment and outcomes for affected women.
Area of Science:
- Neuro-oncology
- Reproductive Medicine
- Pathophysiology
Background:
- Meningiomas are frequent primary intracranial tumors, typically benign but prone to recurrence.
- While common in older adults, meningiomas during pregnancy present unique challenges due to rapid growth and potential life-threatening complications.
- Existing theories on accelerated meningioma growth in pregnancy, involving hormonal and hemodynamic changes, lack definitive evidence.
Purpose of the Study:
- To provide a comprehensive overview of the pathomechanism behind meningioma growth during pregnancy.
- To synthesize findings from advanced research methodologies to elucidate complex growth factors.
- To lay the groundwork for personalized therapeutic strategies and reduced patient mortality.
Main Methods:
- Review of advanced neuropathological data.
- Analysis of molecular biological findings.
- Integration of bioinformatic, imaging, and epidemiological studies.
Main Results:
- Meningioma growth in pregnancy is multifactorial, influenced by complex interactions.
- Hormonal influences and hemodynamic alterations are key suspected contributors.
- Advanced methodologies offer deeper insights into tumor behavior during gestation.
Conclusions:
- A thorough understanding of meningioma pathomechanisms in pregnancy is crucial.
- This knowledge will facilitate the development of tailored therapies.
- Improved understanding aims to reduce the morbidity and mortality associated with pregnancy-related meningiomas.

